SCLERO.ORG
Search

Scleroderma Gastrointestinal Involvement

Author: Shelley Ensz. Scleroderma is highly variable. See Types of Scleroderma. Read Disclaimer
Overview
Biomarkers for Scleroderma GI
Correlation with Other Symptoms
Digestive Involvement
Bowel Dysfunction
Dysmotility Syndrome
Dysphagia (Difficulty Swallowing)
Esophagus (Throat) Involvement
Esophagus: Reflux (Heartburn)
Gastroparesis
Gastroparesis Stories
GAVE (Watermelon Stomach)
Loss of Appetite
Malnutrition
Pneumoperitoneum
Additional Research

Overview: GI Involvement in Systemic Sclerosis (Scleroderma)

GI involvement consists of a variety of symptoms and conditions that include nausea and vomiting, difficulty with swallowing, constipation, diarrhea, GERD (gastroesophageal reflux disease), problems with digestion, gastroparesis, and watermelon stomach.

Some of these symptoms are bothersome and can have a serious affect on your quality of life. Others are life threatening. All should be taken seriously and discussed with your doctor. (Also see Scleroderma Gastrointestinal Involvement, What is Scleroderma?, Types of Scleroderma, and Systemic Sclerosis

How to beat health problems no one likes to talk about. When it comes to digestive troubles we’re remarkably shy, with more than 40 per cent of people never discussing their symptoms with a doctor. Mail Online, 08/22/2017.

Review article: pathogenesis and clinical manifestations of gastrointestinal involvement (GI) in systemic sclerosis (SSc). The pathogenesis of GI in SSc remains elusive and an improved understanding of novel pathogenic mechanisms may allow the development of potentially highly effective approaches, including intravenous immunoglobulin and microRNA based therapeutic interventions. PubMed, Aliment Pharmacol Ther, 2017 Apr;45(7):883-898.

Factors associated with development of gastrointestinal problems in patients with scleroderma: a systematic review. Longitudinal observational studies are warranted, as there is insufficient evidence to describe the risk factors for GI problems in patients with scleroderma. PMC, 12/30/2015.

Systemic Sclerosis: Gastrointestinal Disease and Its Management. Recent studies on the pathophysiology of the disease highlight new mechanisms to explain gastrointestinal dysmotility, but treatment remains symptomatic. PubMed, Rheum Dis Clin North Am, 2015 Aug;41(3):459-73.

Study Demonstrates Benefits of Medical Nutrition Therapy (MNT) Intervention in Systemic Sclerosis (SSc) Patients with Gastrointestinal Involvement (GI). Future studies should include direct measures of body composition and should seek to determine the durability of MNT on symptom improvement in a larger number of patients with SSc involving the GI tract. Scleroderma News, 07/27/2015. (Also see Diet and Scleroderma)

Evaluation and management of gastrointestinal manifestations in scleroderma (SSc). Patient care is being optimized by close collaboration of rheumatologists and gastroenterologists, leading to a more coordinated approach in the management of gastrointestinal manifestations of SSc. PubMed, Curr Opin Rheumatol, 2014 Nov;26(6):621-9.

Biomarkers for GI Involvement in Systemic Scleroderma

Fecal calprotectin in systemic sclerosis and review of the literature. Abnormal fecal calprotectin levels were correlated with gastrointestinal impairment, especially small intestinal bacterial overgrowth (SIBO). Fecal calprotectin (FC) may be a helpful test in identifying the group of systemic sclerosis patients at high risk for SIBO. PubMed, Autoimmun Rev, 2015 Jun;14(6):547-54. (Also see Systemic Sclerosis Prognosis and Mortality: Biomarkers)

Correlation with Other Symptoms

Consider GERD in patients with pulmonary diseases. Gastroesophageal reflux disease (GERD) has been linked to many forms of pulmonary disease. However, because not all presentations of lung diseases include GERD’s more commonly recognized symptoms, it may be missed as a contributing factor. American College of Physicians, March 2014. (Also see Correlation between Pulmonary Fibrosis and other Diseases or Complications)

Sleep disturbances in systemic sclerosis (SSc): evidence for the role of gastrointestinal symptoms, pain and pruritus. Gastrointestinal symptoms, pain and pruritus were associated with sleep disturbance in SSc. Additional research is needed on sleep in SSc so that well-informed sleep interventions can be developed and tested. PubMed, Rheumatology. (Also see Sleep Disorders and Scleroderma, Pain, and Scleroderma Skin Involvement: Itching)

Digestive Involvement

Systemic scleroderma can affect the entire digestive tract, affecting swallowing, digestion, and elimination.

Bowel Involvement

Bowel Involvement. Scleroderma can cause constipation, diarrhea, malabsorption, diminished peristalsis, intestinal pseudo-obstruction, and bowel incontinence. Typical in the initial stages of scleroderma is chronic constipation, sometimes alternating with diarrhea. Late stage scleroderma bowel involvement is often marked by diarrhea, malabsorption, and bowel incontinence. ISN.

Overview
Causes of Bowel Dysfunction
Constipation: Treatments
Diarrhea: Treatments
Bowel Incontinence
Bowel Management
Bowel Surgery
Habba Syndrome
Intestinal Pseudo-Obstruction
Intestinal Bacterial Overgrowth
Inflammatory Bowel Disease (IBD)
—Collagenous Colitis
—Crohn's Disease
—Ulcerative Colitis
Irritable Bowel Syndrome (IBS)
Malabsorption
Peristalsis
Research

Dysmotility Syndrome

Dysmotility syndrome refers to muscles in the gastrointestinal tract not working properly. This can include the throat (esophagus), stomach, and bowels. When the stomach is affected, it is often called gastroparesis. When it affects the bowels, it may be called intestinal pseudo-obstruction. ISN. (Also see Esophagus, Gastroparesis, and Bowel Involvement)

Overview
Symptoms
Diagnosis
Treatment
Correlation with other Complications
Research

Dysphagia (Difficulty Swallowing)

Dysphagia is the medical term for difficulty in swallowing. Symptoms include a sensation of food sticking in the throat, chest pressure or 'burning' after eating, or a feeling of choking. Dysphagia can be due to many different things. Occasionally it is one of the symptoms of systemic scleroderma. ISN.

Overview
Dysphagia Treatments
Liquefied Food for Dysphagia
Enteral or Parenteral Nutrition (TPN)
Dysphagia Personal Stories
References

Esophagus (Throat)

Esophageal (Throat) Involvement. Scleroderma can cause Barrett's Esophagus, esophageal diseases, esophageal stricture, and esophageal ulcers. ISN.

Overview
Air Esophagogram
Barrett's Esophagus
Candida Esophagitis
Correlation with Lung Disease
Dysphonia (Hoarseness, Loss of Voice)
Esophageal Diseases
Esophageal Motility Disorders
Esophageal Spasm
Esophageal Stricture
Esophageal Ulcer
Gastric MALT Lymphoma
Reflux (Heartburn)

Esophagus: Reflux (Heartburn)

Esophagus: Reflux (Heartburn) and GERD. There are many effective treatments and lifestyle modifications for reflux (heartburn) which is very common in scleroderma patients. ISN.

Overview
Cough Due to Heartburn
Heartburn, GERD and Scleroderma
About Reflux (Heartburn)
Hiatal Hernia
About GERD
Reflux and Atrial Fibrillation
Reflux and Lung Involvement
Reflux Prevention and Treatments
Personal Stories

Gastroparesis

What is Gastroparesis? Symptoms, diagnosis, treatments, and support. Gastroparesis and Dysmotilities Association.

Functional Dyspepsia and Gastroparesis. Precise identification of the cause and pathophysiology of upper gastrointestinal symptoms is essential for optimal management. PubMed, Dig Dis, 2016;34(5):491-9.

Gastroparesis Personal Stories

Jason: Linear Scleroderma I have recently been diagnosed with Raynaud's as well, have had gastrointestinal difficulties more common to systemic forms, and have witnessed these lesions grow and deepen rather than decrease in size…

Jody: Fibromyalgia/Difficult Diagnosis In Sudan, I was on IV for heat stroke and food poisoning. And in Thailand, at the end of March, it all came to a crashing halt…

Sandy J: CREST Scleroderma I have had an ileostomy for two years and a feeding peg for just over one year, and would appreciate comments from any person who also has one or both of these problems…

Tami: Morphea Scleroderma I have gotten used to the stares everyone casts my way because in their eyes I am different. Unique, I guess…

Trish: Spouse of a Diffuse Scleroderma Patient My husband was diagnosed with scleroderma in June of 2000…

Loss of Appetite

A loss of appetite can occur for a great many reasons, including anxiety, depression, infection, medication and treatment side-effects, and many illnesses. There are medications that can stimulate appetite, as well as treat nausea. Loss of appetite in a scleroderma patient may be indicative of gastrointestinal involvement. If appetite loss persists, it is important to consult your medical care provider.

Malnutrition

Serum albumin is not useful as a marker for malnutrition in scleroderma.

Intestinal dysbiosis is common in systemic sclerosis (SSc) and associated with gastrointestinal and extraintestinal features of disease. In this cross-sectional study, intestinal dysbiosis was common in patients with SSc and was associated with gastrointestinal dysfunction, malnutrition and with some inflammatory, fibrotic and vascular extraintestinal features of SSc. PubMed, Arthritis Res Ther, 2016 Nov 29;18(1):278. (Also see Diet and Scleroderma)

Pneumoperitoneum

Case Report: Benign Spontaneous Pneumoperitoneum in Systemic Sclerosis (SSc). We report a case of spontaneous pneumoperitoneum (air or gas in the abdominal (peritoneal) cavity) without evidence of peritoneal irritation in a malnourished patient with long-standing SSc. PubMed, J Clin Rheumatol.

Watermelon Stomach

Watermelon Stomach is the popular name for Gastric Antral Vascular Ectasia (GAVE) — a condition in which the lining of the stomach bleeds, causing it to look like the characteristic stripes of a watermelon when viewed by endoscopy. ISN.

What is Watermelon Stomach?
Diagnosis
Treatment
A Patient's Perspective
Watermelon Stomach in Associated with Other Diseases
Patient/Caregiver Stories

Additional Research

Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement (GI) in systemic sclerosis (SSc). Sustained benefit from IVIG suggests a specific immunomodulatory effect on those with established SSc GI complications. PubMed, Rheumatology (Oxford), 08/28/2015. (Also see IVIg)

Nausea and Vomiting Many illnesses can cause stomach pain, nausea and vomiting. Some are mild sicknesses that will pass by themselves, but others are serious and need medical attention. familydoctor.org.

Go to Bowel Dysfunction
 
United Way of Central New Mexico
United Way of Snohomish County
See ISN News for recent donors, including memorials for
Jim Miller, Arlene Marie Petulla, Frances Maude Baldwin Watson and Rubye Mai Blocker Westmoreland.
Thanks to Winn Schillberg for donating to scleroderma research.
Donate or Shop Now
 

TOLL FREE HOTLINE, U.S. and Canada: 1-800-564-7099
Ask for our Free Info Packet by email or postal mail!

SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to:

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA
Email [email protected] to request our Welcome email, or to report bad links or to update this page content. Privacy Policy.
 

The most important thing in the world to know about scleroderma is sclero.org!

Donate Now
Copyright 1998-2017, International Scleroderma Network. AKA Scleroderma from A to Z and SCLERO.ORG. All Rights Reserved.